← All Sponsors
SPONSOR

ALX Oncology Inc.

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Breast Cancer, Metastatic
NCT07007559 Phase 1, Phase 2
Recruiting

ASPEN-09: A Study of Evorpacept in Combination With Anti-cancer Therapies in Advanced / Metastatic Malignancies

Breast Cancer, Metastatic
United States View Trial →